-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly Goodwill history and growth rate for Q3 2025.
- Cyclacel Pharmaceuticals, Inc. Goodwill for the quarter ending September 30, 2025 was $1.57M.